Sarcoidosis is an inflammatory condition of unknown cause that can affect multiple organs. Its hallmark is the formation of noncaseating granulomas—clusters of immune cells within affected tissues.
While the disease can occur at any age, it most commonly presents in young adults. The lungs and chest lymph nodes are most frequently involved, but sarcoidosis may also affect the eyes, skin, joints, heart, kidneys, nervous system, and other organs. Managing this disease often requires a collaborative, multidisciplinary approach to healthcare.
In the United States, sarcoidosis affects an estimated 11 per 100,000 white individuals and 34 per 100,000 African Americans, with a lifetime risk of about 2.4%. Women are more likely to develop skin and eye symptoms, while cardiac complications are seen more often in men. The presentation and severity may vary based on a patient’s age, sex, and ethnicity.
The precise cause of sarcoidosis remains unclear, though genetic and environmental influences are suspected. Certain inherited traits, especially variations in the major histocompatibility complex (MHC), seem to increase susceptibility. Environmental and occupational exposures—such as to beryllium or certain dusts—may play a role, as might specific microorganisms, including mycobacteria and propionibacteria. Rare cases following organ transplantation point to a possible infectious trigger in certain individuals.
The disease process involves an abnormal immune response resulting in the accumulation and activation of T cells, macrophages, and other immune cells. This leads to the formation of granulomas, particularly in the lungs and lymph nodes, but potentially in nearly any organ. Cytokines—such as various interleukins, interferon gamma, and tumor necrosis factor alpha (TNF-α)—play a central role in the development and maintenance of these granulomas. In cases affecting the skin (cutaneous sarcoidosis), T cells, B cells, and elevated TNF levels contribute to the disease. Noncaseating granulomas, which lack the tissue death seen in other granulomatous diseases, are the defining histological feature.
Symptoms of sarcoidosis can vary widely. Many patients are completely asymptomatic and are diagnosed incidentally. When present, symptoms often include a persistent dry cough, shortness of breath, fatigue, and chest discomfort. Other manifestations may include red, tender skin nodules, blurred vision or eye pain from uveitis, hoarseness, or enlarged lymph nodes. Some patients may experience joint pain, neurological symptoms (such as seizures or psychiatric changes), hearing loss, or cardiac issues. In severe cases, complications may include heart rhythm disturbances, pulmonary hypertension, and organ failure.
Sarcoidosis is diagnosed by correlating clinical findings, radiographic evidence, and tissue biopsy results. Imaging, such as chest X-rays or CT scans, may reveal a reticular pattern in the lungs and enlarged hilar lymph nodes. Laboratory tests may show elevated angiotensin-converting enzyme (ACE) levels, hypercalcemia, or increased inflammatory markers. A tissue biopsy—often of lymph nodes or affected organs—confirms the presence of noncaseating granulomas. Other causes of granulomatous disease must be excluded.
Respiratory tests often show a restrictive pattern and reduced diffusion capacity for carbon monoxide (DLCO), especially in advanced cases. About 10% of patients may exhibit an obstructive pattern. If DLCO is below 60% of the predicted value and oxygen desaturation occurs during exertion, further evaluation for pulmonary hypertension is warranted.
Not all patients with sarcoidosis require treatment. Asymptomatic individuals or those with mild, non-progressive disease are typically monitored with regular follow-ups, imaging, and lung function testing. Symptomatic patients or those with progressive organ involvement may require oral corticosteroids, starting at 0.3 to 0.6 mg/kg daily for four to six weeks. If no improvement is seen, therapy may be extended. Steroids should be tapered gradually over several months. For patients who cannot tolerate steroids, alternative immunosuppressive drugs (such as methotrexate, azathioprine, or infliximab) may be used. Lung transplantation may be considered for those with advanced, end-stage pulmonary disease.
The outlook for sarcoidosis varies. Many cases resolve spontaneously, especially when only the lungs or lymph nodes are affected. However, patients with multi-organ involvement or severe symptoms face a more guarded prognosis, with potential for relapse and progressive loss of organ function. The mortality rate in untreated sarcoidosis is around 3–5%, with African American women over 50 at the highest risk.
Optimal management of sarcoidosis relies on a team approach. Primary care providers, pulmonologists, cardiologists, ophthalmologists, radiologists, nurses, pharmacists, and other specialists must coordinate care, monitor for disease progression, address medication side effects, and provide patient education. Regular eye exams, chest imaging, and pulmonary rehabilitation may be recommended as needed.
Sarcoidosis is a complex disease that presents differently in each patient. While many individuals remain asymptomatic or experience spontaneous remission, others may develop significant, potentially life-threatening complications. Early diagnosis, careful monitoring, and a coordinated, multidisciplinary approach are key to improving outcomes and quality of life for those affected.
Source:
Mettapalli R, Patel K, Morrison C. Giant Cell Arteritis.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK430687/
Connect with a lupus specialist who can provide personalised care and treatment plans.
Learn about ANA tests, anti-dsDNA antibodies, and other diagnostic tools used to identify lupus.
Understand genetic, environmental, and hormonal factors that may increase lupus risk.
Access research studies, clinical trials, and evidence-based treatment guidelines.
This information is for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider for diagnosis and treatment recommendations specific to your condition.
